MLH1 and sebaceous adenocarcinoma: Interestingly, a noteworthy underexpression in hMLH1 and hHMS2 was directly reported in sebaceous adenocarcinoma associated with MTS, ranging from 28% to 2% respectively, highlighting this type of malignant SGTs development (14).